Delivery Order SPE2DB22D1106-SPE2DB24FEQY8
- Not listed
- This federal contract award is for the delivery of 4563816196 Ondansetron ODT 4 mg tablets in quantities of 30 to the Defense Logistics Agency (DLA). The $16,342.90 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The ultimate completion date for this order is March 1, 2024. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This federal contract award is for the delivery of Ondansetron ODT 4 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This award is made as a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. The IDC has a ceiling value of $999,999,999.00 and runs through November 2026,...
- This federal contract award is for the delivery of Ondansetron ODT 4 mg tablets to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for a ceiling value of $2,271.95. The contract is a delivery order with a firm fixed-price pricing type and a completion date of January 30, 2024. The award was not set aside for any special designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
- The federal contract award is for the delivery of Ondansetron ODT 4 mg tablets in 30-count packages to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on June 11, 2025, with a ceiling value of $3,739.59 and a completion date of June 12, 2025. The contract is a firm fixed-price delivery order, and it is not set-aside. Amerisourcebergen Drug Corp holds a...
- This federal contract award is for the delivery of Ondansetron ODT 4 mg tablets to the Defense Logistics Agency (DLA). The $1,940.22 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on March 6, 2025. The contract has a completion date of March 7, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is for the delivery of Ondansetron ODT 4 mg tablets in quantities of 30. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $8,939.93 and an ultimate completion date of May 11, 2023. This is a delivery order contract with a firm fixed price pricing type. The contract is not designated with any set-aside requirements, indicating open...
- This federal contract award is for the delivery of Ondansetron ODT 4 mg tablets to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on February 6, 2025, with a ceiling value of $2,586.96 and a completion date of February 7, 2025. The contract is a delivery order with a firm fixed price pricing type. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds an...
- This federal contract award is for the delivery of Ondansetron ODT 8 mg tablets in quantities of 30s. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The contract is a delivery order with a firm fixed price of $4,452.96 and a completion date of June 9, 2025. The contract is not set aside for any particular business type. Amerisourcebergen Drug Corp is the...
- The federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Ondansetron ODT 4 mg tablets. The contract, valued at $13,603.15, is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA). The contract has an ultimate completion date of March 27, 2025 and is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award is for the delivery of Ondansetron ODT 4 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical, which is a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., both of which are for-profit organizations. The contract has a ceiling value of $15,378.69 and a period of performance ending on April 25, 2023. This is a delivery order contract with a firm fixed price pricing type. The...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FEQY8Delivery Order
This federal contract award is for the delivery of Ondansetron ODT 4 mg tablets to the Defense Logistics Agency (DLA). The contract, valued at $6,004.39, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of May 10, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.0k | 5/9/24 |